Evaluating the return of prostatic adenocarcinoma

被引：2

作者：

Berry, MG

Feneley, MR

Domizio, P

Britton, KE

Badenoch, DF

机构：

[1] St Bartholomews Hosp, Royal Hosp NHS Trust, Dept Urol, London EC1A 7BE, England

[2] St Bartholomews Hosp, Royal Hosp NHS Trust, Dept Histopathol, London EC1A 7BE, England

[3] St Bartholomews Hosp, Royal Hosp NHS Trust, Dept Nucl Med, London EC1A 7BE, England

来源：

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE | 1998年 / 91卷 / 12期

关键词：

D O I：

10.1177/014107689809101209

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：641 / 643

页数：3

共 5 条

[1]

BRITTON KE, 1998, CLIN NUCL MED, P481

[2]

Chengazi VU, 1997, J NUCL MED, V38, P675

[3] Prostatic radioimmunoscintigraphy: Preliminary results using technetium-labelled monoclonal antibody, CYT-351 [J].

Feneley, MR ;

Chengazi, VU ;

Kirby, RS ;

Nimmon, CC ;

Granowska, M ;

Mather, SJ ;

Ellison, D ;

Granowski, AR ;

Britton, KE .

BRITISH JOURNAL OF UROLOGY, 1996, 77 (03) :373-381

[4] MINIMAL OR NO CANCER IN RADICAL PROSTATECTOMY SPECIMENS - REPORT OF 13 CASES OF THE VANISHING CANCER PHENOMENON [J].

GOLDSTEIN, NS ;

BEGIN, LR ;

GRODY, WW ;

NOVAK, JM ;

QIAN, JQ ;

BOSTWICK, DG .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (09) :1002-1009

[5]

NEAL GE, 1994, SURG LAPAROSC ENDOSC, V4, P272

← 1 →